Medical

Marijuana Lollipop-Induced Myocardial Infarction

According to a new article published in the Canadian Journal of Cardiology: A 70-year-old man with known coronary artery disease presented with crushing chest pain, diaphoresis, and pallor after consuming a marijuana lollipop; the pain began within 30 minutes of consumption. Full report here: https://www.onlinecjc.ca/article/S0828-282X(18)31324-2/fulltext

North American Cannabis Summit

Via the Boston Globe: I was honored to serve last week as the emcee of the equity-themed 2019 North American Cannabis Summit in Los Angeles, an important gathering of non-industry marijuana stakeholders organized by Massachusetts-based Advocates for Human Potential. When I wasn’t reminding people where to find their bagged lunches,Read More →

The role in understanding the role that THC in pharmaceutical-grade cannabis plays in treating pain takes another step forward. The Regina Leader Post published an article about a recent study conducted in The Netherlands regarding pain mitigation for fibromyalgia patients. A study out of the Netherlands found that standardised pharmaceutical-grade cannabis withRead More →

CBD-Derived Epidiolex Gains FDA Approval for Epilepsy

In an historic first, the U.S. Food and Drug Administration approved the drug Epidiolex for the treatment of children with epilepsy. The FDA-approved prescription of Epidiolex is specifically intended for the treatment of two kinds of very severe epilepsy, namely: Dravet  syndrome and Lennox-Gastaut Syndrome. GW Pharmaceuticals, based in the UK, manufactures theRead More →